BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32538049)

  • 1. Lower Serum miR-145 Predicts Poor Prognosis in Patients with Acute Myeloid Leukemia.
    Shi Q; Xing G; Qi M; Xing Y
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
    Zhang P; Sun D; Sun X; Li H
    Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
    Fang Z; Wang X; Wu J; Xiao R; Liu J
    Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
    Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
    J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.
    Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D
    J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
    Guo Y
    Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia.
    Xu P; Zhou D; Yan G; Ouyang J; Chen B
    Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
    Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients.
    Liu X; Li H
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
    Hong Z; Zhang R; Qi H
    Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
    Wang Y; Li Y; Song HQ; Sun GW
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.
    Xu LH; Guo Y; Cen JN; Yan WY; He HL; Niu YN; Lin YX; Chen CS; Hu SY
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4841-50. PubMed ID: 26744876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.
    Zhi F; Cao X; Xie X; Wang B; Dong W; Gu W; Ling Y; Wang R; Yang Y; Liu Y
    PLoS One; 2013; 8(2):e56718. PubMed ID: 23437222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.